Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Olodaterol is a selective agonist of β2-adrenergic receptors (β2-ARs; EC50s = 97.7 and 2,725 nM for human β2- and β1-ARs, respectively).1 In vivo, olodaterol completely reverses acetylcholine-induced bronchoconstriction without cardiovascular side effects in guinea pigs. It also exhibits dose-dependent bronchoprotection in a beagle model of acetylcholine-induced bronchoconstriction for a period of 24 hours, indicating potential for once-daily dosing.2 Formulations containing olodaterol have been used to treat bronchoconstriction associated with chronic obstructive pulmonary disease.3
WARNING This product is not for human or veterinary use.
1. Discovery of olodaterol, a novel inhaled β2-
2. Pharmacological characterization of olodaterol, a novel inhaled β2-
3. Systematic review comparing LABA, olodaterol, and indacaterol: Limitations. Int. J. Chron. Obstruct. Pulmon. Dis. 9, 1331-1333 (2014).